This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) project grant of $550,000 awarded to the University of Washington aims to develop a non-invasive multiplex blood test for early detection of preeclampsia, a serious pregnancy complication.
The project objectives are to: 1) create multiplexing probes capable of quantifying multiple cell-surface protein biomarkers as an effective, economical, and non-invasive diagnostic tool; and 2) validate the accuracy and specificity of the test in a clinical setting, starting with preeclampsia patients, to enable early-stage prediction and intervention. The research focuses on advancing the detection of vascular dysfunction, particularly preeclampsia, by optimizing a blood test that targets disease-inducing signaling proteins. The project's broader impacts include enhancing maternal health outcomes, providing research and commercialization training to biomedical researchers, and potentially developing a routine prenatal screening tool.
Generated 1/28/25, 10:40 AM